INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2026, Supplement 2

Cardiovasc Metab Sci 2026; 37 (S2)

Post-coronary revascularization mortality according to preoperative left ventricular function in Mexican patients

Borgo-Navarro, Diego Abraham; Gloria-Valencia, Natalia; Flores-Salinas, Héctor Enrique

ABSTRACT

Introduction: coronary artery bypass grafting is the gold standard treatment for patients with complex multivessel disease. While short- and long-term mortality are the clinical outcomes traditionally evaluated, perioperative morbidity assumes critical and decisive importance in high-cardiovascular-risk populations. Currently, there is a gap regarding the validation of traditional risk scores within the Mexican population. Objective: to evaluate the association between preoperative left ventricular function— quantified using systolic and diastolic parameters—and early clinical outcomes in a Mexican population undergoing myocardial revascularization. Material and methods: an observational, analytical, retrospective study was conducted at a tertiary-care hospital. The study included 120 consecutive patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. For analysis, patients were divided into two groups: those with preserved left ventricular ejection fraction (LVEF) (≥ 50%) and those with non-preserved LVEF (‹ 50%). Echocardiographic follow-up was implemented, and a multivariate statistical analysis using Cox regression was performed to evaluate independent risk predictors, comparing them against international predictive scales. Results: fiftyfour patients (45%) presented with non-preserved LVEF. This group exhibited impaired diastolic function (mean e’ wave 6.4 vs. 7.9 cm/s, p = 0.018; E/e’ ratio 11.1 vs. 9.6, p = 0.009). Notably, the EuroSCORE II and STS calculators showed no predictive significance within this cohort. In the multivariate model, non-preserved LVEF quadrupled the risk of early mortality (HR 4.09, p = 0.057). Hospital stay was longer (27.0 vs. 13.4 days, p = 0.021) in patients with ventricular dysfunction. Conclusion: among Mexican patients, non-preserved LVEF and diastolic dysfunction reduce short-term survival and increase morbidity and hospital resource utilization, thereby necessitating comprehensive echocardiographic risk stratification. The lack of predictive capacity of international calculators highlights the urgent need to develop local risk models.
  FULL TEXT PDF   FLIPBOOK

Keywords

coronary artery bypass grafting left ventricular ejection fraction left ventricular dysfunction mortality risk stratification




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Reverse right atrial remodeling following tricuspid valve-in-valve implantation...
    2026, Vol.37, Núm. S2
  • 10. Prevención y rehabilitación
    2026, Vol.37, Núm. S2
  • 1.2. Premio Dr. Carlos Pérez Treviño
    2026, Vol.37, Núm. S2
  • 9. Circulación pulmonar y trombosis
    2026, Vol.37, Núm. S2
  • 13. Secciones emergentes e interdisciplinarias
    2026, Vol.37, Núm. S2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 37, Num. S2, Octubre-Diciembre 2026. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 29 de octubre de 2026.

 

2026     |     https://www.cardiovascularandmetabolicscience.org.mx/